I received an email from John Harris yesterday regarding a new study for JAK inhibitors. This is a great way for you to get FREE medicine and hopefully have the results you want! I would love to participate in this study but unfortunately no longer have Vitiligo on my face (which is a requirement).
In order to qualify for this study, you must meet a certain set of requirements, known as inclusion criteria. Some of the key inclusion criteria are as follows:
- You are 18 to 65 years of age
- You have been diagnosed with non-segmental vitiligo by a healthcare professional
- You have vitiligo on your face
- You have vitiligo on other parts of your body besides face
- You agree to discontinue all treatments you use to treat vitiligo while you are participating in the clinical trial, including creams, phototherapy, and any oral medicines
- You are healthy overall and have normal blood work up and labs
This trial is now seeking to enroll 330 eligible patients world wide. It will last for approximately a year and requires a total 19 visits to the clinic over the course of the study. It is a randomized, double-blind, dose-ranging clinical trial, which means patients will randomly be placed in groups with some patients receiving the study drug at different doses while others receive a control drug (placebo group) that does not contain any medication. Various doses of the study drug will be tested. The study drug to placebo ratio is 5:1 – in other words, you will have an 83% chance of being on the actual drug and a 17% chance of being on placebo during the first 6 months (24 weeks) of the study.
Link to the survey:
https://go.umassmed.edu/e/184882/redcap-surveys--s-W7RJXHMJ7L/2r7cdc2/2314370027?h=C_-Vq_pCbhHkzzVYvZMKCpA1MepT1PCPSXwScy0A9BE
Study info:
Replies
Bless you for taking the time to share this information. I did not choose regimentation as the way to resolve my vitiligo (I decided to depigment); however, that is not to say that ALL forms of vitiligo are resistant to complete and long-term repigmenatation.
I hope you're doing well, Sue.
Kindest regards,
Jackie Renaud